biotech / news / / South China Morning Post
Nuwacell Biotechnologies was founded a decade ago in Hefei, Anhui province.
Nuwacell Biotechnologies claims their stem cell therapy achieves 80–90% neuron conversion efficiency.
KEY POINTS
- International competitors reportedly achieve less than 25% conversion of stem cells to dopaminergic neurons.
- Nuwacell's clinical trial timeline is faster than US and Japanese teams, the company asserts.
- The company was founded by Yu Junying and Zhang Ying, both returning from leading US institutions.
COMPANIES
Summarized by Newsio from South China Morning Post. How we summarize →